Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

The microRNA (miR)-200s and their negative regulator ZEB1 have been extensively studied in the context of the epithelial–mesenchymal transition. Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis, whereas replacement of miR-200 miRNAs has been shown to inhibit cell growt...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Ther
Päätekijät: Cortez, Maria Angelica, Valdecanas, David, Zhang, Xiaochun, Zhan, Yanai, Bhardwaj, Vikas, Calin, George A, Komaki, Ritsuko, Giri, Dipak K, Quini, Caio C, Wolfe, Tatiana, Peltier, Heidi J, Bader, Andreas G, Heymach, John V, Meyn, Raymond E, Welsh, James W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4435581/
https://ncbi.nlm.nih.gov/pubmed/24791940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2014.79
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia